Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization

Journal of Vascular Surgery

Volumn 49, Issue 5, 2009, Pages

  Protack, Clinton D ^a   Bakken, Andrew M ^a   Xu, Jiaqiong ^a   Saad, Wael A ^a   Lumsden, Alan B ^a   Davies, Mark G ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CAROTID REVASCULARIZATION; CAROTID STENT; DATA BASE; DIABETES MELLITUS; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MORBIDITY; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; REVASCULARIZATION; STENT; STROKE; SURGICAL MORTALITY;

EID: 64949164687     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.12.011     Document Type: Article

References (32)

1. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
2. Isomaa B., Almgren P., Tuomi T., Forsén B., Lahti K., Nissén M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
3. Wallenfeldt K., Hulthe J., and Fagerberg B. The metabolic syndrome in middle-aged men according to different definitions and related changes in carotid artery intima-media thickness (IMT) during 3 years of follow-up. J Intern Med 258 (2005) 28-37
4. Iannuzzi A., De Michele M., Bond M.G., Sacchetti L., Fortunato G., Salvatore F., et al. Carotid artery remodeling in middle-aged women with the metabolic syndrome (from the "Progetto ATENA" study). Am J Cardiol 96 (2005) 1162-1165
5. Scuteri A., Najjar S.S., Muller D.C., Andres R., Hougaku H., Metter E.J., and Lakatta E.G. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 43 (2004) 1388-1395
6. Palomo I., Alarcón M., Moore-Carrasco R., and Argilés J.M. Hemostasis alterations in metabolic syndrome (review). Int J Mol Med 18 (2006) 969-974
7. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Bonadonna R.C., et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 26 (2003) 1251-1257
8. Anand S.S., Yi Q., Gerstein H., Lonn E., Jacobs R., Vuksan V., Teo K., et al. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 108 (2003) 420-425
9. Koren-Morag N., Goldbourt U., and Tanne D. Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack: a prospective cohort study in patients with atherosclerotic cardiovascular disease. Stroke 36 (2005) 1366-1371
10. McGirt M.J., Woodworth G.F., Brooke B.S., Coon A.L., Jain S., Buck D., et al. Hyperglycemia independently increases the risk of perioperative stroke, myocardial infarction, and death after carotid endarterectomy. Neurosurgery 58 (2006) 1066-1072 discussion 1073
11. Echahidi N., Mohty D., Pibarot P., Després J.P., O'Hara G., Champagne J., et al. Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery. Circulation 116 11 Suppl (2007) I213-I219
12. Theron J.G., Payelle G.G., Coskun O., Huet H.F., and Guimaraens L. Carotid artery stenosis: treatment with protected balloon angioplasty and stent placement. Radiology 201 (1996) 627-636
13. Alberti K.G., Zimmet P., Shaw J., and IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
14. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
15. Yadav J.S., Wholey M.H., Kuntz R.E., Fayad P., Katzen B.T., Mishkel G.J., et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351 (2004) 1493-1501
16. Baker J.D., Rutherford R.B., Bernstein E.F., Courbier R., Ernst C.B., Kempczinski R.F., et al. Suggested standards for reports dealing with cerebrovascular disease: Subcommittee on Reporting Standards for Cerebrovascular Disease, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg 8 (1988) 721-729
17. Gorter P.M., Olijhoek J.K., van der Graaf Y., Algra A., Rabelink T.J., Visseren F.L., and SMART Study Group. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis 173 (2004) 363-369
18. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., Lenfant C., et al., American Heart Assoc. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
19. Einhorn D., Reaven G.M., Cobin R.H., Ford E., Ganda O.P., Handelsman Y., et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 9 (2003) 237-252
20. Bloomgarden Z.T. Definitions of the insulin resistance syndrome: the 1st World Congress on the Insulin Resistance Syndrome. Diabetes Care 27 (2004) 824-830
21. Executive Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholestexrol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
22. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
23. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. http://www.diabetes.com.au/pdf/who_report.pdf Accessed on May 14, 2008
24. Lev-Ran A. Human obesity: an evolutionary approach to understanding our bulging waistline. Diabetes Metab Res Rev 17 (2001) 347-362
25. Winter Y., Rohrmann S., Linseisen J., Lanczik O., Ringleb P.A., Hebebrand J., and Back T. Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks. Stroke 39 (2008) 3145-3151
26. Rockman C.B., Saltzberg S.S., Maldonado T.S., Adelman M.A., Cayne N.S., Lamparello P.J., and Riles T.S. The safety of carotid endarterectomy in diabetic patients: clinical predictors of adverse outcome. J Vasc Surg 42 (2005) 878-883
27. Ballotta E., Da Giau G., and Renon L. Is diabetes mellitus a risk factor for carotid endarterectomy?. A prospective study. Surgery 129 (2001) 146-152
28. Kahn S.E., Haffner S.M., Iese M.A., Herman W.H., Colman R.R., Jones N.P., et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 355 (2006) 2427-2443
29. Romera C., Hurtado O., Mallolas J., Pereira M.P., Morales J.R., Romera A., et al. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection. J Cereb Blood Flow Metab 27 (2007) 1327-1338
30. Shimazu T., Inoue I., Araki N., Asano Y., Sawada M., Furuya D., et al. A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemia. Stroke 36 (2005) 353-359
31. Sundarajan S., Gamboa J.L., Victor N.A., Wanderi E.W., Lust W.D., and Landreth G.E. Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience 130 (2005) 685-696
32. Pereira M.P., Hurtado O., Cárdenas A., Boscá L., Castillo J., Dávalos A., et al. Rosiglitazone and 15-deoxy-delta 12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. J Cereb Blood Flow Metab 26 (2006) 218-229